Testing effectiveness (Phase 2)Study completedNCT00916578What this trial is testingXeloda (Capecitabine) and External Beam RadiationWho this might be right forBreast Cancer M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT00796978What this trial is testingTrastuzumab in Treating Older Women With Early-Stage Breast CancerWho this might be right forBreast Cancer Cynthia Owusu, MD 56
Testing effectiveness (Phase 2)Study completedNCT00043017What this trial is testingMagnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast CancerWho this might be right forBreast Cancer American College of Radiology Imaging Network 356
Early research (Phase 1)Active Not RecruitingNCT02264678What this trial is testingAscending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsWho this might be right forAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer AstraZeneca 358
Testing effectiveness (Phase 2)Ended earlyNCT04862143What this trial is testingPilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With FulvestrantWho this might be right forAdvanced Breast Cancer Novartis Pharmaceuticals 2
Not applicableStudy completedNCT00900094What this trial is testingUMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerWho this might be right forBreast CancerColorectal CancerEsophageal Cancer+4 more University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00313170What this trial is testingA Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mgWho this might be right forAdvanced Breast CancerMetastatic Breast Cancer AstraZeneca 144
Testing effectiveness (Phase 2)Study completedNCT05850637What this trial is testingEvaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast CancerWho this might be right forBreast Cancer Female Prevent Senior Institute 60
Early research (Phase 1)Study completedNCT01286987What this trial is testingStudy of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsWho this might be right forAdvanced or Recurrent Solid TumorsBreast NeoplasmsOvarian Cancer, Epithelial+4 more Pfizer 113
Not applicableLooking for participantsNCT06431100What this trial is testingA Single-arm, Single-center, Open Clinical StudyWho this might be right forGastric CancerEsophageal CancerCervical Cancer+2 more Beijing Geekgene Technology Co., LTD 10
Early research (Phase 1)WithdrawnNCT00074139What this trial is testingDocetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast CancerWho this might be right forBreast Cancer Case Comprehensive Cancer Center
Not applicableUnknownNCT04953377What this trial is testingPFMT Educational Intervention for Patients With Advancer Breast CancerWho this might be right forAdvanced Breast Cancer Onkologikoa 42
Not applicableUnknownNCT01655004What this trial is testingProspective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PDWho this might be right forBreast Carcinoma National University Hospital, Singapore 110
Testing effectiveness (Phase 2)Study completedNCT00003428What this trial is testingHormone Therapy in Treating Women With Breast CancerWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 114
Early research (Phase 1)UnknownNCT02950064What this trial is testingDetermine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsWho this might be right forPancreatic NeoplasmsOvarian NeoplasmsBreast Neoplasms+1 more Placon Therapeutics 95
Early research (Phase 1)Study completedNCT02077933What this trial is testingStudy of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic TumorsWho this might be right forNeoplasmsBreast NeoplasmsKidney Neoplasms+1 more Novartis Pharmaceuticals 79
Testing effectiveness (Phase 2)Study completedNCT02756364What this trial is testingSapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor TherapyWho this might be right forBreast Neoplasms Calithera Biosciences, Inc 141
Testing effectiveness (Phase 2)Study completedNCT00856492What this trial is testingS0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast CancerWho this might be right forBreast Cancer SWOG Cancer Research Network 215
Testing effectiveness (Phase 2)Study completedNCT02860000What this trial is testingAlisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast CancerWho this might be right forEstrogen Receptor StatusHER2/Neu NegativeInvasive Breast Carcinoma+6 more Mayo Clinic 96
Testing effectiveness (Phase 2)Looking for participantsNCT05824975What this trial is testingEvaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Who this might be right forAdvanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more GI Innovation, Inc. 358